DK2097079T3 - Modulering af prostaglandin/cyclooxygenase-metabolske veje - Google Patents

Modulering af prostaglandin/cyclooxygenase-metabolske veje

Info

Publication number
DK2097079T3
DK2097079T3 DK07870407.9T DK07870407T DK2097079T3 DK 2097079 T3 DK2097079 T3 DK 2097079T3 DK 07870407 T DK07870407 T DK 07870407T DK 2097079 T3 DK2097079 T3 DK 2097079T3
Authority
DK
Denmark
Prior art keywords
prostaglandin
modulation
metabolic pathways
cyclooxygenase
cyclooxygenase metabolic
Prior art date
Application number
DK07870407.9T
Other languages
Danish (da)
English (en)
Inventor
Ernst Wuelfert
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Priority claimed from PCT/GB2007/004584 external-priority patent/WO2008065408A2/en
Application granted granted Critical
Publication of DK2097079T3 publication Critical patent/DK2097079T3/da

Links

DK07870407.9T 2006-11-30 2007-11-29 Modulering af prostaglandin/cyclooxygenase-metabolske veje DK2097079T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86787306P 2006-11-30 2006-11-30
GB0623971A GB0623971D0 (en) 2006-11-30 2006-11-30 Modulation of prostaglandin/cyclooxygenase metabolic pathways
PCT/GB2007/004584 WO2008065408A2 (en) 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways

Publications (1)

Publication Number Publication Date
DK2097079T3 true DK2097079T3 (da) 2012-10-01

Family

ID=37671641

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07870407.9T DK2097079T3 (da) 2006-11-30 2007-11-29 Modulering af prostaglandin/cyclooxygenase-metabolske veje

Country Status (9)

Country Link
CN (1) CN101594861B (es)
DK (1) DK2097079T3 (es)
ES (1) ES2390182T3 (es)
GB (1) GB0623971D0 (es)
NZ (1) NZ577075A (es)
PT (1) PT2097079E (es)
RS (1) RS52453B (es)
RU (1) RU2448712C2 (es)
SI (1) SI2097079T1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
TWI692359B (zh) * 2019-02-25 2020-05-01 大江生醫股份有限公司 乳酸菌的代謝產物及其用於護肺的用途
CN111777613A (zh) * 2019-04-03 2020-10-16 中国药科大学 嘧啶二酮并吲哚和吡啶酮并吲哚类化合物的制备及用途
CN113905732A (zh) * 2019-04-09 2022-01-07 纽罗比特科学有限公司 用于预防或治疗脊髓损伤或椎管狭窄的药物组合物
CN111394289B (zh) * 2019-12-20 2021-06-11 合肥康诺生物制药有限公司 一种基因工程菌及其应用,生产前列腺素e2的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363984A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
FR2829697B1 (fr) * 2001-09-14 2004-03-19 Mayoly Spindler Lab Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Also Published As

Publication number Publication date
CN101594861A (zh) 2009-12-02
GB0623971D0 (en) 2007-01-10
CN101594861B (zh) 2013-06-12
RS52453B (en) 2013-02-28
RU2009124917A (ru) 2011-01-10
SI2097079T1 (sl) 2012-10-30
RU2448712C2 (ru) 2012-04-27
ES2390182T3 (es) 2012-11-07
NZ577075A (en) 2012-01-12
PT2097079E (pt) 2012-09-24

Similar Documents

Publication Publication Date Title
NL350090I2 (nl) flupyradifurone
DK2317851T3 (da) Anvendelse af 5-fluorcytosin som fungicid
DK3225251T3 (da) Modulering af pro-neurotrofinaktivitet
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2219469T3 (da) Modificering af enzymatisk disponerede proteiner
DK3296284T3 (da) Ikke-terapeutisk anvendelse af hydroxybutyratester
DK2269063T3 (da) Forudsigelse af risiko for større uønskede hjertehændelser
DK2153565T3 (da) Valg af transmissionsmodus
DK2180787T3 (da) Nitrooliesyremodulering af type ii-diabetes
DK2187741T3 (da) Hidtil ukendte former af cddo-methylester
DK2024504T4 (da) Fremstilling af isoprenoider
DK1877568T4 (da) Hydrolysering af arabinoxylan
DK3208269T3 (da) Inhibitorer af c-fms-kinase
DK2371818T3 (da) Hydroxybenzoatsalte af metanikotinforbindelser
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK1986947T3 (da) Installation af offshore-konstruktioner
BRPI0909448A2 (pt) composição adesiva polimerizável
DK2700786T3 (da) Modifikation af overførselspassage
DK2031948T3 (da) Bestemmelse af en komponents brugstid
DK2117542T3 (da) Kombinationer af beta-2-adrenoceptor-agonistisk benzothiazolon
DK2114147T3 (da) Reduktion af bivirkninger af tramadol
DK1917227T3 (da) Krystalformer af astaxanthin
DK2117732T3 (da) Frembringelse af partier
DK2280962T5 (da) Pyridazinonderivater
DK2083629T3 (da) Krystallinsk modifikation af fipronil